Morgan Stanley
BIOX icon

Morgan Stanley’s Bioceres Crop Solutions BIOX Stock Holding History

Morgan Stanley’s Portfolio BIOX Stock Details BIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.31K Sell
18,014
-47
-0.3% -$22 ﹤0.01% 7156
2026
Q1 		$8.04K Buy
18,061
+12,664
+235% +$9.61K ﹤0.01% 7013
2025
Q4 		$7.07K Sell
5,397
-14,669
-73% -$23.5K ﹤0.01% 6974
2025
Q3 		$28.3K Sell
20,066
-43,723
-69% -$133K ﹤0.01% 6584
2025
Q2 		$285K Sell
63,789
-31,862
-33% -$144K ﹤0.01% 5709
2025
Q1 		$437K Sell
95,651
-14,134
-13% -$77.8K ﹤0.01% 5392
2024
Q4 		$667K Buy
109,785
+40,136
+58% +$274K ﹤0.01% 5298
2024
Q3 		$548K Hold
69,649
– – ﹤0.01% 5360
2024
Q2 		$781K Sell
69,649
-39,535
-36% -$462K ﹤0.01% 5103
2024
Q1 		$1.38M Buy
109,184
+71,717
+191% +$945K ﹤0.01% 4793
2023
Q4 		$514K Buy
37,467
+35,301
+1,630% +$413K ﹤0.01% 5277
2023
Q3 		$24.5K Sell
2,166
-534
-20% -$6.4K ﹤0.01% 6424
2023
Q2 		$36.1K Sell
2,700
-10,063
-79% -$118K ﹤0.01% 6343
2023
Q1 		$148K Sell
12,763
-1,720
-12% -$20.2K ﹤0.01% 5842
2022
Q4 		$174K Sell
14,483
-1,072
-7% -$13.9K ﹤0.01% 5722
2022
Q3 		$202K Buy
15,555
+5,331
+52% +$65.5K ﹤0.01% 5724
2022
Q2 		$140K Sell
10,224
-2,395
-19% -$31.8K ﹤0.01% 6089
2022
Q1 		$172K Buy
12,619
+2,500
+25% +$33K ﹤0.01% 6000
2021
Q4 		$143K Buy
10,119
+2,500
+33% +$34.6K ﹤0.01% 6243
2021
Q3 		$103K Sell
7,619
-893
-10% -$12K ﹤0.01% 6355
2021
Q2 		$120K Buy
8,512
+893
+12% +$12.6K ﹤0.01% 6270
2021
Q1 		$78K Sell
7,619
-1,109
-13% -$9.31K ﹤0.01% 6139
2020
Q4 		$54K Sell
8,728
-891
-9% -$5.07K ﹤0.01% 6140
2020
Q3 		$52K Buy
+9,619
New +$54.5K ﹤0.01% 5709

Other funds holding BIOX

SP
Solel Partners Boston, Massachusetts $588M AUM 14.47% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $83.9B AUM 60.43% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
PCM
Ping Capital Management New York $401M AUM 32.08% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Morgan Stanley's BIOX Position: Q2 2026 in Review

Morgan Stanley reduced its Bioceres Crop Solutions (BIOX) stake by 0.26% in Q2 2026, selling an estimated $22 and leaving 18,014 shares worth $6.31K. The position accounts for ﹤0.01% of the portfolio, ranked #7156.

Morgan Stanley first reported a position in BIOX in Q3 2020 and has held it in 24 quarters since. The position peaked at $1.38M in Q1 2024. 28 funds tracked by Wall St. Rank hold BIOX as of Q2 2026.

  • Morgan Stanley held 18,014 shares of Bioceres Crop Solutions worth $6.31K as of Q2 2026.
  • Morgan Stanley sold 47 Bioceres Crop Solutions shares in Q2 2026, an estimated $22.
  • Bioceres Crop Solutions made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #7156 holding.
  • Morgan Stanley first reported a position in Bioceres Crop Solutions in Q3 2020 and has held it in 24 quarters since.
  • Morgan Stanley's Bioceres Crop Solutions position peaked at $1.38M in Q1 2024.
  • 28 funds tracked by Wall St. Rank held Bioceres Crop Solutions as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.